JPRN-jRCT1091220083招募中3 期
Clinical Trial of bilateral bevacizumab administration in patient with retinopathy of prematurity
obuhisa Naoi, MDDepartment of Ophthalmology, School of medicine University of Miyazaki0 个研究点目标入组 80 人开始时间: 2012年3月13日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 <= 6month old（—）
- 性别
- All
入选标准
- •Patient with retinopathy of prematurity admitted in Miyazaki University Hospital
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Phase II Trial of Bevacizumab in Combination with XELOX in Colorectal Cancer Patients with Liver Metastases (H2, H3)colorectal liver metastasesJPRN-UMIN000002897iigata Colorectal cancer Chemotherapy Study Group (NCCSG)20
进行中（未招募）
不适用
Phase II clinical study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic breast cancerMetastatic or locally recurrent HER2-negative breast cancerMedDRA version: 12.0Level: LLTClassification code 10055113Term: Breast cancer metastaticMedDRA version: 12.0Level: LLTClassification code 10006198Term: Breast cancer recurrentEUCTR2009-016062-82-HUSOUTH EASTERN EUROPEAN RESEARCH ONCOLOGY GROUP88
招募中
1 期
Phase I/II Trial of Bevacizumab in Combination With FOLFOXIRI As First-Line Therapy in Colorectal Cancer Patients With Liver Metastasescolorectal cancer patients with fore or more liver metastasesJPRN-UMIN000005413Yokohama City University School of Medicine23
已完成
2 期
Phase II trial of the addition of bevacizumab to alectinib beyond progressive disease in ALK-positive advanced non-small-cell lung cancer.ALK-positive non-small cell lung cancerJPRN-UMIN000017828iigata Lung Cancer Treatment Group11
招募中
不适用
A clinical study of Bevacizumab therapy in combination with chemotherapeutic drugs for children with recurrent gliomaJPRN-UMIN000005528Osaka University Graduate School of Medicine12